Healthcare provider profile · identity verified

Lindsey K Busch, ARNP

Nurse Practitioner · SOUTH DAYTONA, FL · NPI 1710470299

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	362	122
Amlodipine Besylate	Amlodipine Besylate	300	101
Lisinopril	Lisinopril	264	79
Levothyroxine Sodium	Levothyroxine Sodium	230	79
Omeprazole	Omeprazole	197	57
Albuterol Sulfate Hfa	Albuterol Sulfate	195	63
Rosuvastatin Calcium	Rosuvastatin Calcium	189	62
Metoprolol Succinate	Metoprolol Succinate	172	50
Gabapentin	Gabapentin	169	66
Losartan Potassium	Losartan Potassium	164	58
Pantoprazole Sodium	Pantoprazole Sodium	157	51
Hydrochlorothiazide	Hydrochlorothiazide	139	43
Metformin Hcl	Metformin Hcl	135	45
Trazodone Hcl	Trazodone Hcl	113	37
Sertraline Hcl	Sertraline Hcl	111	34
Furosemide	Furosemide	108	38
Metoprolol Tartrate	Metoprolol Tartrate	101	34
Alendronate Sodium	Alendronate Sodium	98	36
Methylprednisolone	Methylprednisolone	97	74
Pravastatin Sodium	Pravastatin Sodium	92	21
Fluticasone Propionate	Fluticasone Propionate	73	27
Buspirone Hcl	Buspirone Hcl	69	21
Azithromycin	Azithromycin	68	56
Clopidogrel	Clopidogrel Bisulfate	66	16
Eliquis	Apixaban	63	24
Ezetimibe	Ezetimibe	63	18
Lovastatin	Lovastatin	62	17
Doxazosin Mesylate	Doxazosin Mesylate	58	15
Allopurinol	Allopurinol	56	11
Potassium Chloride	Potassium Chloride	55	13
Prednisone	Prednisone	52	18
Memantine Hcl	Memantine Hcl	51	suppressed
Simvastatin	Simvastatin	49	18
Ibuprofen	Ibuprofen	48	22
Escitalopram Oxalate	Escitalopram Oxalate	44	15
Duloxetine Hcl	Duloxetine Hcl	43	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	suppressed
Ondansetron Odt	Ondansetron	43	suppressed
Tizanidine Hcl	Tizanidine Hcl	41	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	15
Carvedilol	Carvedilol	40	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	suppressed
Glipizide	Glipizide	39	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	14
Meloxicam	Meloxicam	38	16
Famotidine	Famotidine	36	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	31
Tramadol Hcl	Tramadol Hcl	34	25
Jardiance	Empagliflozin	33	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Atenolol	Atenolol	31	suppressed
Chlorthalidone	Chlorthalidone	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Ozempic	Semaglutide	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	12
Cephalexin	Cephalexin	26	24
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	18
Bupropion Xl	Bupropion Hcl	21	suppressed
Estradiol	Estradiol	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	18	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Levonorgestrel-Eth Estradiol	Levonorgestrel/Ethin.Estradiol	16	suppressed
Ramipril	Ramipril	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Nystatin	Nystatin	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Baclofen	Baclofen	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Fluocinonide	Fluocinonide	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Ibu	Ibuprofen	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Elmiron	Pentosan Polysulfate Sodium	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Naproxen	Naproxen	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error